Global Advanced Drug Delivery Systems Market 2021
- گزارش بازار
- شناسه: HL21496G
- زمان تحویل: 1 روز کسب و کار
- برچسب بزنید: Advanced Drug Delivery Systems
شرح
Drug delivery technologies play an increasingly important role in the drug-development process as a means to improve the efficacy of a drug, make a drug safer, more effective, or convenient, extend its patent life, or differentiate it in the marketplace. The global advanced drug delivery systems market in terms of revenue is set to grow by US$ 74 میلیارد در طول 2021-2027, رشد با نرخ رشد مرکب سالانه (CAGR) از 5.1% در طول دوره پیش بینی, بر اساس داده ها و شرکت تحلیلی StrategyHelix. Growth in the geriatric population, increasing prevalence of chronic diseases, increase in average income, rising demand for healthcare, rising demand for effective drug delivery design are the key factors driving market growth.
این گزارش داده های به روز اندازه بازار را برای دوره ارائه می دهد 2017-2020 و پیش بینی به 2027 covering key market aspects like sales value for advanced drug delivery systems. The global advanced drug delivery systems market is segmented on the basis of type, drug delivery carrier, کاربرد, و منطقه. بر اساس نوع, it is categorized into oral drug delivery, injection-based drug delivery, inhalation/pulmonary drug delivery, transdermal drug delivery, transmucosal drug delivery, و دیگران. The oral drug delivery segment held the largest market share in 2020. By drug delivery carrier, the advanced drug delivery systems market is divided into nanoparticles, monoclonal antibodies, liposomes, prodrugs, microparticles, dendrimer, و دیگران. The nanoparticles segment accounted for the largest market share in 2020. Based on application, the advanced drug delivery systems market is divided into cardiovascular, central nervous system (CNS), diabetes, inflammatory & آلرژی, oncology, ophthalmic, respiratory, urology, و دیگران.
The report has profiled some of the key players of the market such as Abbott Laboratories, Amgen Inc., AstraZeneca plc, Baxter International Inc., Bayer HealthCare Pharmaceuticals Inc., Boston Scientific Corporation, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck KGaA, Novartis International AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd..
این گزارش منبع ارزشمندی برای شرکت ها و سازمان های فعال در این صنعت است. It provides a cohesive picture of the advanced drug delivery systems market to help drive informed decision making for industry executives, سیاست گذاران, علمی, و تحلیلگران.
دامنه گزارش
تایپ کنید: oral drug delivery, injection-based drug delivery, inhalation/pulmonary drug delivery, transdermal drug delivery, transmucosal drug delivery, و دیگران
Drug delivery carrier: nanoparticles, monoclonal antibodies, liposomes, prodrugs, microparticles, dendrimer, و دیگران
کاربرد: cardiovascular, central nervous system (CNS), diabetes, inflammatory & آلرژی, oncology, ophthalmic, respiratory, urology, و دیگران
منطقه: آمریکای شمالی, آسیا و اقیانوسیه, اروپا, و بقیه جهان (ROW)
سال های در نظر گرفته شده: این گزارش دوره را پوشش می دهد 2017 به 2027
مزایای کلیدی برای ذینفعان
Get a comprehensive picture of the global advanced drug delivery systems market
شناسایی استراتژی های منطقه ای و اولویت های استراتژیک بر اساس داده ها و تحلیل های محلی
بخش های رشد و روند سرمایه گذاری را مشخص کنید
Understand what the future of the global advanced drug delivery systems market looks like
چشم انداز رقابتی و پنجره فرصت را شناسایی کنید
فهرست مطالب
1. تعریف بازار
2. روش تحقیق
3. داده های بازار & چشم انداز
3.1 ارزش بازار
3.2 پیش بینی ارزش بازار
4. Advanced Drug Delivery Systems Market by Type
4.1 Oral Drug Delivery
4.2 Injection-Based Drug Delivery
4.3 Inhalation/Pulmonary Drug Delivery
4.4 Transdermal Drug Delivery
4.5 Transmucosal Drug Delivery
4.6 دیگران
5. Advanced Drug Delivery Systems Market by Drug Delivery Carrier
5.1 Nanoparticles
5.2 Monoclonal Antibodies
5.3 Liposomes
5.4 Prodrugs
5.5 Microparticles
5.6 Dendrimer
5.7 دیگران
6. Advanced Drug Delivery Systems Market by Application
6.1 Cardiovascular
6.2 Central Nervous System (Cns)
6.3 Diabetes
6.4 Inflammatory & Allergies
6.5 Oncology
6.6 Ophthalmic
6.7 Respiratory
6.8 Urology
6.9 دیگران
7. Advanced Drug Delivery Systems Market by Region
7.1 آمریکای شمالی
7.2 آسیا و اقیانوسیه
7.3 اروپا
7.4 بقیه دنیا (ردیف)
8. مشخصات شرکت
8.1 Abbott Laboratories
8.2 Amgen Inc.
8.3 AstraZeneca plc
8.4 Baxter International Inc.
8.5 Bayer HealthCare Pharmaceuticals Inc.
8.6 Boston Scientific Corporation
8.7 F. Hoffmann-La Roche AG
8.8 GlaxoSmithKline plc.
8.9 Merck KGaA
8.10 Novartis International AG
8.11 Pfizer Inc.
8.12 Sanofi SA
8.13 Teva Pharmaceutical Industries Ltd.
9. ضمیمه
9.1 درباره StrategyHelix
9.2 سلب مسئولیت
دلار آمریکا 2,750